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Abstract: The purpose of the study is to review the administration of pain relief medications in acute post-operative 
phase and compare the drug therapy after major surgical interventions in inpatient care units in order to assure quality of 
pain management. 
A double-group comparative study design was chosen using observations as comparison of examining pain regimens in 
two surgical units by comparing the 4-year recorded post-operative drug regimens of a total of 1054 patients after major 
surgical interventions; hip and knee replacements in Traumatology and the post-operative drug regimen administered 
following major surgical intervention at the department of Gynaecology, respectively. 
The results of the study suggest significant difference in medications, and dosage forms of medications used for acute 
post-operative pain relief through 4 consecutive years at Traumatology and Gynaecology. At the in patient unit of 
Traumatology the administration of Tramadol hydrochloride droplets has significantly increased while at Gynaecology the 
use of Nalbuphine hydrochloride ampoules showed significant increase. The results indicate that pain relief, even in 
acute therapy, requires effective and accurately administered doses. The latter, as this study points out, could be 
successfully solved with the conventional droplet dosage form. Inter-professional collaboration of doctors, clinical 
pharmacists and nurses has an impact to provide patients with successful, adequate and individually customized pain 
relief methods.  
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INTRODUCTION 
Undermanaged post-operative pain remains a 
widespread problem despite the development of 
specialized acute pain regimens over the past 20 years 
[1, 2]. A major review [3] and a systematic review [4] 
similarly confirm the difficulties of providing effective 
post-operative pain management to large populations 
of surgical patients; 70-90% of the cases the care 
provided is inadequate. At the same time the 
consequences of the under managed post-operative 
pain are obvious and are preventable by collaboration 
of inter-professional health care providers in the 
process of acute post-operative pain management. 
Guidelines for managing acute pain exist at a local 
level in many hospitals, but the published guidelines 
may be influenced by local factors, such as: ward 
routines, the available surgical and anaesthetic 
experience and skills, cultural and social preferences, 
and the availability of International Guidelines [5, 6]. 
Patients’ perspectives on pain management have 
mainly been addressed with descriptions of their 
experience [7]. 
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Many post-operative analgesic regimens rely on 
patients to self-administer analgesics following surgical 
interventions. For example, a patient may be given a 
prescription for tablets and told to take one every few 
hours as needed. The importance of effective pain 
control in minimizing the deleterious effects of the 
surgically induced stress response and improving 
outcome from surgery is now well recognized [8, 9]. 
The view has therefore arisen that such information 
needs to be procedure-specific, since the analgesic 
efficacy of drugs varies between different types of 
surgery: e.g. the analgesic efficacy of paracetamol is 
twofold less in orthopaedic procedures compared with 
dental procedures [10]. In addition, the difference in 
analgesic efficacy between non-steroidal anti-
inflammatory agents (NSAIDs) and paracetamol has 
been demonstrated to depend on the magnitude of 
surgery [11]. Optimal dynamic pain relief, allowing early 
function, is a prerequisite for accelerated postoperative 
rehabilitation (fast-track surgery) [8], and therefore the 
clinician needs procedure-specific information in order 
to optimize the choice of analgesia. Further supporting 
a need for procedure-specific information is the fact 
that the intensity of pain and the consequential effects 
on organ functions may be procedure-related. The 
purpose of the study is to review and analyze the 
administration of pain relief medications in acute post-
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operative phase, compare the drug therapies, including 
drug forms after major surgical interventions in 
inpatient care units and point out the roles of inter-
professional health care providers, such as 
pharmacists, in the process of acute post-operative 
pain management.  
METHODS 
Sample Selection 
A retrospective cohort study was carried out based 
on data analysis from the reporting system of the Toldy 
Ferencz hospital for the 4-year period from January 
2006 through December 2009. These data coded and 
abstracted from the health record after recovery of 
surgical interventions is completed, contain 
demographic and up to 4 diagnosis codes. A sample of 
individuals is selected to compare pain regimens in two 
surgical units of a metropolitan hospital of Cegléd, 
Hungary by comparing the 4-year recorded (Y1-Y4) 
post-operative drug regimens over a thousand patients 
(1054). The hospital has 50 acute beds at 
Traumatology and 50 beds for acute in-patient care at 
Gynaecology. The total number of beds for acute care 
at the hospital is 458 (www.OEP.hu, 2009). 
In 2009: at the inpatient care department of 
Traumatology 1718 surgical interventions, including hip 
and knee surgeries, were performed; and 1974 surgical 
interventions, including uterus removals, were 
performed at the inpatient Department of Gynaecology. 
(http://www.toldykorhaz.hu, 2009).  
The 1054 patients have received analgesics, as part 
of the acute pain management therapy, after major 
surgical interventions, such as: hip and knee 
replacements in Traumatology (408 female patients, 
291 male patients) and Gynecology (355 female 
patients) at the department of Toldy Ferencz inpatient 
care centre. 
Figure 1 illustrates the age-distribution of patients at 
Traumatology after hip and knee replacement 
interventions, respectively. Knee replacements were 
chosen because knee is the one most affected by pain, 
which is exposed to great forces in daily activities and 
the knee is the most treated anatomical region, being 
responsible for 26% of all visits to orthopaedists [12]. 
The recorded data were stratified according to mode of 
analgesic delivery and type of agent for the 
comparison. Figure 2 shows that of the patients after 
uterus removal at Gynaecology. The samples of the 
age-distribution of patients (Figures 1 and 2) follow a 
gaussain distribution. Table 1 shows the active 
ingredients of Analgesics, NSAIDs and Opioids that are 
used in accordance with International Guidelines for 
Acute Pain Management. 
 
Figure 1: Age distribution of patients treated at 
Traumatology. 
 
Figure 2: Age distribution of patients treated at Gynecology. 
The NSAIDs are a group of chemically 
heterogeneous compounds with anti-inflammatory, 
analgesic, and antipyretic effects, excluding 
acetaminophen, which lacks significant anti-
inflammatory properties [13]. 
The term “narcotic”, which initially referred to a drug 
that induces stupor, has been replaced by “opioid” 
(drugs related to opium), a more appropriate 
pharmacologic designation for a class of medications 
used to treat pain. The pharmacodynamic (e.g., 
potency) and pharmacokinetic (e.g., rate and route of 
elimination) properties of various agents differ 
significantly, changes in drug, dosing, and route of 
administration cannot be carried out without 
considering equianalgesic equivalents on a drug and 
dose basis [14, 15]. Equianalgesic guidelines are 
available which provide information about 
approximately equivalent doses between drugs and 
routes of administration [16].  
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Table 1: Analgesics, NSAIDs, and Opioids that are used 
in accordance with International Guidelines for 
Acute Pain Management WHO Collaborating 
Centre for Drug Statistics Methodology, 2003 
[16] 
Analgesics and NSAIDs Opioids 
acetylsalicylic acid 
diclofenac sodium 
ibuprofen 
indomethacin 
naproxen 
paracetamol 
phenylbutazone 
codeine 
morphine sulfate 
pentazocine 
pethidine 
tramadol 
 
Hypothesis Testing 
The chi-square test [17] is used to test if a sample 
of data came from a population with a specific 
distribution. 
Chi-square test was made for both groups to check 
whether there are any differences between the years. 
The null hypothesis was that there is no difference in 
the post-operative drug regimen administered for 
subsequent years. The significance level was set at 
5%. SPSS 11.5 statistical program package was used 
for the calculations. 
RESULTS AND DISCUSSION 
Figures 3 and 4 illustrate the changes of the number 
patients treated with analgesics after major surgical 
interventions in acute post-operative phase as a 
function of time. 
 
Figure 3: Post-operative active pain relief therapy at 
Gynaecology as a function of the duration if analgesic use. 
Table 2 illustrates the brand names of marketing 
authorized products, their active ingredients, and the 
ATC codes of medications used for Acute Pain Relief 
and were administered from 2006 to 2009 at 
Traumatology in acute Post-operative Phase, while 
Table 3 summarizes those were applied within the 
same period at Gynaecology in acute Post-operative 
Phase after uterus removal as part of the recovery. 
 
Figure 4: Duration (days) of active pain relief treatment at 
Traumatology. 
Table 2: The Applied Drugs for Acute Pain Relief within 
2006-2009 at Traumatology 
Brand Name Active Ingredient ATC 
Algopyrin Metamizole sodium N02BB02 
Cataflam Diclofenac M01AB05 
Contramal Tramadol N02AX02 
Demalgonil 
Allobarbital, 
aminophenazone 
N02BB73 
Panadol Paracetamol N02BE01 
Panalgorin Metamizole sodium N02BB02 
 
Table 3: The Applied Drugs for Acute Pain Relief within 
2006-2009 at Gynaecology 
Brand Name Active Ingredient ATC 
Algopyrin Metamizole sodium N02BB02 
Contramal Tramadol N02AX02 
Nubain Nalbuphine N02AF02 
Panalgorin Metamizole sodium N02BB02 
 
We have reviewed descriptive statistics for 
Traumatology and Gynaecology data, separately. 
Results of the descriptive statistical analysis (including 
frequency tables and diagrams) show that there are 
major differences in the types of drugs used in the four 
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year period for both groups. These changes do not 
show systematic differences either in the direction or 
magnitude over the years (2006-2009).  
Table 4 summarizes the results of the descriptive 
statistics for Traumatology and Gynaecology 
separately. In fact, only seven of the thirty two drugs 
are used for all the years for Traumatology and only 
five of the sixteen drugs for Gynecology. For example, 
as new drugs are introduced others appear less 
frequently. The seven drugs that appear in each year in 
Traumatology include: Algopyrin ampullas, Cataflam 
capsules, Contramal capsules, Contramal droplets, 
Demalgonil ampullas, Panadol tablets, Panalgorin 
tablets* (*marketing authorized products including their 
dosage forms), while the five drugs that appeared for 
Gynaecology include: Algopyrin ampullas, Contramal 
ampullas, Contramal capsules, Nubain ampullas, 
Panalgorin tablets* (*marketing authorized products 
including their dosage forms). 
Pearson correlation was calculated to assess the 
relationship between the treatments for the years. The 
coefficients were minor and not significant. Table 5 
summarizes the results of the hypothesis testing. Zero 
hypothesis was that there was no difference in the 
post-operative drug regimen administered for the four 
consecutive years (Y1-Y4 referring to 2006-2009) and 
there is no significant difference among years (2006 to 
2007), (2007 to 2008), and (2008 to 2009). The results 
of the chi-square tests have shown that there have 
been significant differences. The p value was smaller 
than 0.001 for all cases.  
Significant differences were pronounced among the 
drugs administered for the four consecutive years. It 
appears that pure opioid agonist was not given for pain 
control in the study population.  
The appearance of generics could replace the 
original drugs (i.e.: Cataflam was replaced by Fortedol). 
Table 4: Comparison of the Descriptive Statistics for Traumatology and Gynaecology Concerning the Applied 
Marketing Authorized Medicines 
Marketing 
authorized 
products 
2006 2007 2008 2009 
Brand Names Gynecol. Traum. Gynecol. Traum. Gynecol. Traum Gynecol. Traum 
Algopyrin amp 0.68 0.22 1.18 0.15 0.30 0.08 0.59 0.56 
Cataflam tbl 0.82 9.88 0.00 12.63 0.10 11.15 0.00 4.45 
Contramal amp 2.47 0.08 4.12 0.76 5.55 0.58 2.82 0.62 
Contramal 
droplets 
0.00 107.00 0.00 44.37 0.00 86.17 0.00 135.44 
Contramal caps 5.21 1.38 0.39 2.55 2.15 3.64 0.12 3.94 
Demalgonil amp 0.00 0.11 0.00 0.10 0.00 0.05 0.53 0.30 
Nubain amp 0.55 0.05 1.18 0.10 3.75 0.06 8.35 0.01 
Panadol tbl 0.00 0.02 0.59 0.15 0.00 2.02 0.18 0.34 
Panalgorin tbl 0.55 0.30 1.76 1.35 0.70 2.22 0.59 1.50 
Gynecol: Gynaecology inpatient care unit; Traum: Traumatology inpatient care unit 
 
Table 5: Results of the Hypothesis Testing 
In-patient unit Years Chi-square (??) test Degree of freedom P value Results 
Traumatology Y1-Y2 925.157 7 p < 0.001 significant difference 
 Y2-Y3 339.767 7 p < 0.001 significant difference 
 Y3-Y4 822.294 7 p < 0.001 significant difference 
Gynaecology Y1-Y2 114.941 4 p < 0.001 significant difference 
 Y2-Y3 62.856 4 p < 0.001 significant difference 
 Y3-Y4 52.359 4 p < 0.001 significant difference 
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The proportional application of Fortedol instead of 
Cataflam was observed. The appearance of Fortedol 
tablets can be attributed to launching of new generics 
to the market. The administration of droplet dosage 
form of Contramal is significantly increased. This 
conventional droplet dosage form enables accurate 
dosing due to its equianalgesic property compare to 
Tramadol capsules. In addition, the oral administration 
of Contramal droplets, in contrast to the solid dosage 
forms of the active ingredient of the oral medications, 
has the advantages of better, more sensitive dosing in 
pain relief, and better side effect profile due to the 
possibility of their sensitive, drop-by-drop dosing.  
CONCLUSIONS 
The results of this study suggest that the adequate 
acute post-operative pain relief regimen is the base of 
quality assurance of pain management and is the 
essential component of accelerated recovery. 
The prescribed and administered drug therapies at 
both inpatient units are part of and included the 
Protocol of the Department of Anaesthesiology and 
Intensive Therapy, Collegium Medium, (http://www. 
drdiag.hu). 
We observed that new methods of administration, 
delivery systems and dosage forms have evolved over 
past five years in the area of postoperative pain 
management. Launching of new generics has impact 
on the administered pain relief medications as 
substitutes to the original medications. Providing 
effective pain control is a central role in postoperative 
phase to assure accelerated recovery. This study 
points out that the understanding of the administration 
of the adequate and effective dosage forms of 
analgesics is paramount to providing optimal pain relief 
in acute post-operative pain management. The 
advantages and also disadvantages, such as: side 
effect profile of each dosage form must be considered 
when selecting the best form for administration. 
Pharmacists have a significant role to play in 
collaboration with other health care professional to find 
the best dosage forms for patients with individual pain 
relief needs to assure quality of care. 
Finally, pain management therapy is part of the 
postsurgical phase of recovery. Since pharmacists 
work in inter-professional collaboration with other 
health care providers, bear a responsibility for 
therapies used for controlling pain from surgery assure 
patients` recovery and help the implementation of the 
best evidence based medicine focusing on adequacy 
and patient safety. 
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